…stry were monitored to evaluate the efficacy and safety.Results RPT and Cy treatment alter the endogenous immune landscape in the m…
4articles mentioning treatments
10treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: RPT ×
RPT
This treatment is selected. Its supporting articles are shown below.
Articles mentioning RPT
4 articles · page 1 of 1RPT177Lu-PSMA-617metastatic castration-resistant prostate cancermetastatic castration-resistant prostate cancer (mCRPC)mCRPCcyclophosphamideCyNCT03873805
RPT[67Cu]Cu-LLP2Aneuroblastomasolid tumors[ 67Cu]Cu-LLP2A67Cu]Cu-LLP2Ahematological malignanciesSK-N-ASNIH institutional IACUCNB
…he tumors in both SK-N-AS and IMR-5.Conclusions [ 67Cu]Cu-LLP2A RPT improves CAR T-cell efficacy by direct tumoricidal effects and …
RPT68Ga]D3-6cancer[177Lu]D3-6
… retention, thereby boosting its immune-activating potential in RPT. Following two rounds of screening, a series of fluorinated D-p…
RPTpancreatic cancers177Lu-A2DM177Lu-RPTCity of Hope Institutional Animal Care and Use Committee177Lu169Tm-A2DM225Ac-A2DM225Ac-RPTA2DM
…Tm-A2DM (10-100µg), and tumors harvested at 48 hr. For low-dose RPT, mice were administered 225Ac-A2DM or 177Lu-A2DM, and tumors co…